BFS Molecular Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
BFS Molecular General Information
Description
Developer of molecular diagnostics software intended to transform the way post-transplantation patient care is practiced. The company provides post-transplant monitoring tests, using the latest NGS - Next Generation Sequencing technology on the reliable and scalable Illumina platforms as well as offers novel approaches and quality results, helping physicians with early detection of transplant rejection or disease relapse.
Contact Information
Website
www.bfsmolecular.comCorporate Office
- Strada Sportului 13A
- Corbeanca, Ilfov
- Tamasi, 077068
- Romania
Corporate Office
- Strada Sportului 13A
- Corbeanca, Ilfov
- Tamasi, 077068
- Romania
BFS Molecular Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
BFS Molecular Comparisons
Industry
Financing
Details
BFS Molecular Competitors (17)
One of BFS Molecular’s 17 competitors is Ariel(Decision/Risk Analysis), a Venture Capital-Backed company based in Pittsburgh, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ariel(Decision/Risk Analysis) | Venture Capital-Backed | Pittsburgh, PA | ||||
Congenica | Venture Capital-Backed | Cambridge, United Kingdom | ||||
PierianDx | Private Equity-Backed | Creve Coeur, MO | ||||
Fabric Genomics | Venture Capital-Backed | Oakland, CA | ||||
GenoSpace | Corporate Backed or Acquired | Cambridge, MA |
BFS Molecular FAQs
-
When was BFS Molecular founded?
BFS Molecular was founded in 2017.
-
Where is BFS Molecular headquartered?
BFS Molecular is headquartered in Tamasi, Romania.
-
What industry is BFS Molecular in?
BFS Molecular’s primary industry is Outcome Management (Healthcare).
-
Is BFS Molecular a private or public company?
BFS Molecular is a Private company.
-
What is BFS Molecular’s current revenue?
The current revenue for BFS Molecular is
. -
Who are BFS Molecular’s competitors?
Ariel(Decision/Risk Analysis), Congenica, PierianDx, Fabric Genomics, and GenoSpace are some of the 17 competitors of BFS Molecular.
-
When was BFS Molecular acquired?
BFS Molecular was acquired on 17-Mar-2021.
-
Who acquired BFS Molecular?
BFS Molecular was acquired by CareDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »